Showing posts with label genetic disorders. Show all posts
Showing posts with label genetic disorders. Show all posts

Monday, June 13, 2016

The Man Who Had No Heart

Stan Larkin lived for 555 without a heart.
Image: Shutterstock
It’s a story that sounds like science fiction, but it’s true: a Michigan man lived for 555 days without a heart. Stan Larkin, a 25-year-old from Ypsilanti, had his real heart removed in November of 2014, but there wasn’t a heart to replace it. Instead, Larkin received an artificial heart, called a “Freedom Driver,” whose power source he carried with him in a backpack. The artificial heart allowed him to live a mostly normal life at home so he didn’t have to wait in the hospital for a transplant.

Larkin didn’t know anything was wrong with his heart until nine years ago. He suddenly collapsed while playing basketball, and doctors discovered he had a genetic heart condition called arrhythmogenic dysplasia, which causes arrhythmias and failure on both sides of the heart. This condition occurs when heart muscles stretch and enlarge at least one heart chamber, so blood can’t pump the way it’s supposed to.

Larkin’s brother, Dominque, also has the condition. But while Dominique only had to use his artificial heart for six weeks before he received a transplant, Larkin had to wait much longer. Doctors decided that because Larkin was doing so well with the machine he could leave the hospital with it to see if he could live an ordinary life.

“I was shocked when the doctors started telling me that I could live without a heart in my body and that a machine was going to be my heart. Just think about it—a machine,” Larkin said. The machine Larkin took home with him included chambers and four valves, like an organic heart. Two tubes that exited Larkin’s body under his ribcage connected the device to a 13-pound power source called the Freedom Driver, which was carried in the backpack.

The machine both powered the artificial heart and delivered compressed air into its ventricles so that blood could be pumped through the rest of Larkin’s body. Larkin says that the device felt just like a real heart. “It’s just in a bag with tubes coming out of you, but other than that, it feels real,” he said. The device had to be replaced about ten times because Larkin was living such an active life.

Larkin was able to have a successful heart transplant 555 days since the Freedom Driver was implanted. He is doing well and recovering quickly, and he’s glad to be healthy again. Larkin’s situation is very promising for other people waiting for transplants.

“I think there’s good science here, and there have been really great advancements in this area,” said Dr. Laman Gray, chair of cardiovascular surgery at Jewish Hospital at the University of Louisville. “We’re making great progress, and people are living normal lives. There’s definitely a place for total artificial hearts and a need for them.”

Friday, April 3, 2015

Non-Invasive Prenatal Testing Slow to Catch on in German

NIPT screens for genetic disorders like Down syndrome using fetal DNA within the mother's bloodstream
NIPT analyzes fetal DNA to screen for genetic disorders like Down syndrome.
Image: Shutterstock
In my last post, I explored some of the most common fertility myths out there. I'm going to be continuing on that chain of thought today by discussing non-invasive prenatal testing (NIPT), which analyzes fetal DNA in order to screen for some of the most common genetic disorders, such as Down syndrome. It can be used for any pregnancy, but is most useful for pregnancies in women above the age of 35. NIPT test results are not 100% guaranteed, but they are highly accurate.

Despite its non-invasive nature and high level of accuracy, however, NIPT hasn’t quite caught on in some countries. For example, Germany has been slow to embrace the idea; however, diagnostic labs are beginning to push the idea more frequently as technology improves and the potential need grows. In 2012, for instance, there were almost 675,000 births in Germany, many of which were of “above average risk.”

Companies such as Amedes, whose board includes prominent members like Rene Kern, and LifeCodexx, run by chairman and co-founder Peter Pohl, are moving forward with options based on the latest technological advancements, making them safer and easier to use than ever before.

NIPT is primarily used to test high-risk pregnancies that might develop any of the common fetal trisomy disorders (Down syndrome, trisomy 18, and trisomy 13) during the first and second trimesters.  The test has to be completed early on by an experienced ultrasound examiner.  Unlike previously used tests, NIPT is, as its name implies, noninvasive. It also doesn’t run the risk of miscarriage, since it only involves taking a small blood sample from the mother.

NIPT must be done within 11 weeks of gestational age.  The currently approved indications are advanced maternal age (35 or over at the time of delivery), positive results on other prenatal screenings, fetal abnormalities in the ultrasound, or a previous pregnancy with chromosomal abnormality.  The tests available right now in Germany are LifeCodexx’s PrenaTest and Amedes’s Panorma Test.

So why hasn’t NIPT taken Germany by storm?  The difficulty lies in the emotional and psychological issues surrounding the testing.  The results could potentially lead parents to decide to terminate a pregnancy, depending on the level of genetic abnormality.  Consequently, a significant amount of psychological counseling is required before parents decide to move forward with the test.

On the other hand, NIPT offers the parents a chance to get the support and information they need to deal with a possibly challenging birthing process.  And with advances in technology, the whole process is far less invasive than it has been in the past.
Google